Prof. Dr. Luís Carlos Lopes-Júnior holds a Bachelor of Science in Nursing (BSc.N)/Registered Nurse (RN) from the Marília Medical School (FAMEMA, Brazil), as well as a Master of Science (MSc.) and Ph.D. in Science from the University of São Paulo (USP) at Ribeirão Preto College of Nursing—a WHO/PAHO Collaborating Centre for Research Development. He is an Oncology-Certified Nurse (OCN). Also, he was a visiting researcher at the University of Alberta (UofA), in Edmonton, AB, Canada, during his doctoral internship (fellow) in 2015. His research interests focus on the assessment and management of the psychoneurological symptom clusters in oncology (e.g., cancer-related fatigue, psychological stress, anxiety, depression, etc.), and on the identification of the biological mechanism of common symptom clusters that occur as a result of cancer and/or its treatments through the circadian rhythms of potential immunological and endocrine biomarkers, in order to predict these symptoms for
therapeutic targets. In addition, he has research interests in public health, cancer epidemiology, as well as systematic reviews and meta-analyses.
Prof. Dr. Luís Carlos Lopes-Júnior holds a Bachelor of Science in Nursing (BSc.N)/Registered Nurse (RN) from the Marília Medical School (FAMEMA, Brazil), as well as a Master of Science (MSc.) and Ph.D. in Science from the University of São Paulo (USP) at Ribeirão Preto College of Nursing—a WHO/PAHO Collaborating Centre for Research Development. He is an Oncology-Certified Nurse (OCN). Also, he was a visiting researcher at the University of Alberta (UofA), in Edmonton, AB, Canada, during his doctoral internship (fellow) in 2015. His research interests focus on the assessment and management of the psychoneurological symptom clusters in oncology (e.g., cancer-related fatigue, psychological stress, anxiety, depression, etc.), and on the identification of the biological mechanism of common symptom clusters that occur as a result of cancer and/or its treatments through the circadian rhythms of potential immunological and endocrine biomarkers, in order to predict these symptoms for
therapeutic targets. In addition, he has research interests in public health, cancer epidemiology, as well as systematic reviews and meta-analyses.